Cargando…
A typology of cerebral small vessel disease based on imaging markers
BACKGROUND: Lacunes, microbleeds, enlarged perivascular spaces (EPVS), and white matter hyperintensities (WMH) are brain imaging features of cerebral small vessel disease (SVD). Based on these imaging markers, we aimed to identify subtypes of SVD and to evaluate the validity of these markers as part...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511610/ https://www.ncbi.nlm.nih.gov/pubmed/37368130 http://dx.doi.org/10.1007/s00415-023-11831-x |
_version_ | 1785108181048885248 |
---|---|
author | Sperber, Christoph Hakim, Arsany Gallucci, Laura Seiffge, David Rezny-Kasprzak, Beata Jäger, Eugen Meinel, Thomas Wiest, Roland Fischer, Urs Arnold, Marcel Umarova, Roza |
author_facet | Sperber, Christoph Hakim, Arsany Gallucci, Laura Seiffge, David Rezny-Kasprzak, Beata Jäger, Eugen Meinel, Thomas Wiest, Roland Fischer, Urs Arnold, Marcel Umarova, Roza |
author_sort | Sperber, Christoph |
collection | PubMed |
description | BACKGROUND: Lacunes, microbleeds, enlarged perivascular spaces (EPVS), and white matter hyperintensities (WMH) are brain imaging features of cerebral small vessel disease (SVD). Based on these imaging markers, we aimed to identify subtypes of SVD and to evaluate the validity of these markers as part of clinical ratings and as biomarkers for stroke outcome. METHODS: In a cross-sectional study, we examined 1207 first-ever anterior circulation ischemic stroke patients (mean age 69.1 ± 15.4 years; mean NIHSS 5.3 ± 6.8). On acute stroke MRI, we assessed the numbers of lacunes and microbleeds and rated EPVS and deep and periventricular WMH. We used unsupervised learning to cluster patients based on these variables. RESULTS: We identified five clusters, of which the last three appeared to represent distinct late stages of SVD. The two largest clusters had no to only mild or moderate WMH and EPVS, respectively, and favorable stroke outcome. The third cluster was characterized by the largest number of lacunes and a likewise favorable outcome. The fourth cluster had the highest age, most pronounced WMH, and poor outcome. Showing the worst outcome, the fifth cluster presented pronounced microbleeds and the most severe SVD burden. CONCLUSION: The study confirmed the existence of different SVD types with different relationships to stroke outcome. EPVS and WMH were identified as imaging features of presumably early progression. The number of microbleeds and WMH severity appear to be promising biomarkers for distinguishing clinical subgroups. Further understanding of SVD progression might require consideration of refined SVD features, e.g., for EPVS and type of lacunes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-023-11831-x. |
format | Online Article Text |
id | pubmed-10511610 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105116102023-09-22 A typology of cerebral small vessel disease based on imaging markers Sperber, Christoph Hakim, Arsany Gallucci, Laura Seiffge, David Rezny-Kasprzak, Beata Jäger, Eugen Meinel, Thomas Wiest, Roland Fischer, Urs Arnold, Marcel Umarova, Roza J Neurol Original Communication BACKGROUND: Lacunes, microbleeds, enlarged perivascular spaces (EPVS), and white matter hyperintensities (WMH) are brain imaging features of cerebral small vessel disease (SVD). Based on these imaging markers, we aimed to identify subtypes of SVD and to evaluate the validity of these markers as part of clinical ratings and as biomarkers for stroke outcome. METHODS: In a cross-sectional study, we examined 1207 first-ever anterior circulation ischemic stroke patients (mean age 69.1 ± 15.4 years; mean NIHSS 5.3 ± 6.8). On acute stroke MRI, we assessed the numbers of lacunes and microbleeds and rated EPVS and deep and periventricular WMH. We used unsupervised learning to cluster patients based on these variables. RESULTS: We identified five clusters, of which the last three appeared to represent distinct late stages of SVD. The two largest clusters had no to only mild or moderate WMH and EPVS, respectively, and favorable stroke outcome. The third cluster was characterized by the largest number of lacunes and a likewise favorable outcome. The fourth cluster had the highest age, most pronounced WMH, and poor outcome. Showing the worst outcome, the fifth cluster presented pronounced microbleeds and the most severe SVD burden. CONCLUSION: The study confirmed the existence of different SVD types with different relationships to stroke outcome. EPVS and WMH were identified as imaging features of presumably early progression. The number of microbleeds and WMH severity appear to be promising biomarkers for distinguishing clinical subgroups. Further understanding of SVD progression might require consideration of refined SVD features, e.g., for EPVS and type of lacunes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-023-11831-x. Springer Berlin Heidelberg 2023-06-27 2023 /pmc/articles/PMC10511610/ /pubmed/37368130 http://dx.doi.org/10.1007/s00415-023-11831-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Communication Sperber, Christoph Hakim, Arsany Gallucci, Laura Seiffge, David Rezny-Kasprzak, Beata Jäger, Eugen Meinel, Thomas Wiest, Roland Fischer, Urs Arnold, Marcel Umarova, Roza A typology of cerebral small vessel disease based on imaging markers |
title | A typology of cerebral small vessel disease based on imaging markers |
title_full | A typology of cerebral small vessel disease based on imaging markers |
title_fullStr | A typology of cerebral small vessel disease based on imaging markers |
title_full_unstemmed | A typology of cerebral small vessel disease based on imaging markers |
title_short | A typology of cerebral small vessel disease based on imaging markers |
title_sort | typology of cerebral small vessel disease based on imaging markers |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511610/ https://www.ncbi.nlm.nih.gov/pubmed/37368130 http://dx.doi.org/10.1007/s00415-023-11831-x |
work_keys_str_mv | AT sperberchristoph atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT hakimarsany atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT galluccilaura atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT seiffgedavid atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT reznykasprzakbeata atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT jagereugen atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT meinelthomas atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT wiestroland atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT fischerurs atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT arnoldmarcel atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT umarovaroza atypologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT sperberchristoph typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT hakimarsany typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT galluccilaura typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT seiffgedavid typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT reznykasprzakbeata typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT jagereugen typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT meinelthomas typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT wiestroland typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT fischerurs typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT arnoldmarcel typologyofcerebralsmallvesseldiseasebasedonimagingmarkers AT umarovaroza typologyofcerebralsmallvesseldiseasebasedonimagingmarkers |